IDEAS指南[Doerfel,H.,等人根据掺入监测数据估算承诺有效剂量的一般准则。报告FZKA7243,卡尔斯鲁厄Forschungszentrum,GmbH(2006);Castellani,C.M.,马什,J.W.,赫尔根,C.,Blanchardon,E.,Berard,P.,Giusani,A.和洛佩兹,M.A.IDEAS指南(第2版),用于根据合并监测数据估算承诺剂量。EURADOS报告2013-01,不伦瑞克(2013)]提供了评估放射性核素摄入量的结构化方法。为了检查指导方针,当应用于典型的监测方案时,导致可靠的评估,已使用该指南构建和评估了许多数字生成的数据集。通过评估获得的剂量和摄入量可以与“真实”剂量和摄入量进行比较。这样,当应用于核工业中通常使用的监测计划时,可以检查IDEAS评估过程的准确性。模拟重点是由于尿常规样本中Pu活性升高(239)而进行的评估,这导致提供后续的尿液和粪便样本。评估者对肺溶解度做出正确的初始假设的情况可以与该初始选择错误的情况进行比较。讨论了这些模拟的结果以及对使用监视程序的意义。
The IDEAS
Guidelines [Doerfel, H., et al General
Guidelines for the Estimation of Committed Effective Dose from Incorporation Monitoring Data. Report FZKA 7243, Forschungszentrum Karlsruhe, GmbH (2006); Castellani, C. M., Marsh, J. W., Hurtgen, C., Blanchardon, E., Berard, P., Giusani, A. and Lopez, M. A. IDEAS
Guidelines (Version 2) for the Estimation of Committed Doses from Incorporation Monitoring Data. EURADOS Report 2013-01, Braunschweig (2013)] provide a structured approach to the assessment of intakes of radionuclides. In order to check that the
guidelines, when applied to typical monitoring programmes, lead to reliable assessments, a number of numerically-generated datasets have been constructed and assessed using the
guidelines. The dose and intake obtained by the assessment can be compared with the \'true\' dose and intake. In this way, the accuracy of the IDEAS assessment process can be examined when applied to monitoring programmes that are typically used in the nuclear industry. The simulations focus on assessments carried out as a result of elevated (239)Pu activities in routine urine samples, which lead to follow-up urine and faecal samples being provided. Cases where the assessor makes the correct initial assumption about lung solubility can be compared with cases where this initial choice is wrong. The results of these simulations and the implication for the use of monitoring programmes are discussed.